Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evogene (EVGN) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Evogene (EVGN) over the last 13 years, with Q3 2025 value amounting to $730000.0.

  • Evogene's Change in Receivables rose 15419.45% to $730000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $972000.0, marking a year-over-year increase of 14318.08%. This contributed to the annual value of -$627000.0 for FY2024, which is 5660.9% up from last year.
  • Per Evogene's latest filing, its Change in Receivables stood at $730000.0 for Q3 2025, which was up 15419.45% from $1.5 million recorded in Q2 2025.
  • In the past 5 years, Evogene's Change in Receivables registered a high of $1.5 million during Q2 2025, and its lowest value of -$1.5 million during Q1 2025.
  • Over the past 5 years, Evogene's median Change in Receivables value was $55000.0 (recorded in 2022), while the average stood at -$17526.3.
  • Within the past 5 years, the most significant YoY rise in Evogene's Change in Receivables was 58181.82% (2023), while the steepest drop was 242000.0% (2023).
  • Evogene's Change in Receivables (Quarter) stood at -$791000.0 in 2021, then soared by 184.7% to $670000.0 in 2022, then plummeted by 252.99% to -$1.0 million in 2023, then skyrocketed by 131.61% to $324000.0 in 2024, then surged by 125.31% to $730000.0 in 2025.
  • Its Change in Receivables stands at $730000.0 for Q3 2025, versus $1.5 million for Q2 2025 and -$1.5 million for Q1 2025.